SCHEMBL13634251

SCHEMBL13634251

CNCNCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17383354 0.78 PRMT3 (0.32)
SCHEMBL18054741 0.78
SCHEMBL7053928 0.74
SCHEMBL1359350 0.73
Bromide SCHEMBL28667693 0.72
Iodide SCHEMBL28654692 0.72
Hydrochloric Acid SCHEMBL28658437 0.72
SCHEMBL17383911 0.72
SCHEMBL16303452 0.71 EPHX1 (0.48)
SCHEMBL13702072 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024127022-A1 HETEROCYCLIC COMPOUNDS TARGETING THE NUDT5 PROTEIN OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2024-06-20 WO disclosed
EP-2695881-A1 GUANIDINE COMPOUND Astellas Pharma Inc. (JP) 2014-02-12 EP disclosed
US-7622592-B2 Carbonylamino-benzimidazole derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-11-24 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090048276-A1 Inhibitors of Fatty Acid Synthase (Fas) MERCK SHARP & DOHME CORP. 2009-02-19 US disclosed
US-7485649-B2 Inhibitors of checkpoint kinases MERCK & CO., INC. (US) 2009-02-03 US disclosed
US-20080274107-A1 Tyrosine kinase inhibitors MERCK SHARP & DOHME CORP. 2008-11-06 US disclosed
US-20080214594-A1 Inhibitors Of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-09-04 US disclosed
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed